NCT06131801 Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution Status RECRUITING Phase N/A
NCT06104878 A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone Status WITHDRAWN Phase N/A
NCT06090864 ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells Status RECRUITING Phase PHASE1/PHASE2
NCT06059391 CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT06045195 Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06002828 Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors Status RECRUITING Phase N/A
NCT05977673 Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy Status RECRUITING Phase PHASE2
NCT05974410 Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Status AVAILABLE Phase N/A
NCT05972577 Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study Status COMPLETED Phase NA
NCT05922904 PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05871008 Integrated Actionable Aging Assessment for Cancer Patients Pilot Status ACTIVE_NOT_RECRUITING Phase NA
NCT05840575 Investigating Cognitive Impairment in Young Patients With Cancer Prospectively Status RECRUITING Phase N/A
NCT05839210 Lifestyle Intervention of Food and Exercise for Lymphoma Survivors Status RECRUITING Phase NA
NCT05798897 Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma Status RECRUITING Phase PHASE1
NCT05757466 Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma Status RECRUITING Phase PHASE2
NCT05723055 Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05663983 Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients Status UNKNOWN Phase N/A
NCT05660993 Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma Status UNKNOWN Phase PHASE2
NCT05627115 Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma Status NOT_YET_RECRUITING Phase PHASE2